Impact of roflumilast on exacerbations of COPD, health care utilization, and costs in a predominantly elderly Medicare Advantage population
Keran Moll,1 Shawn X Sun,2 Jeffrey J Ellis,1 Andrew Howe,1 Alpesh Amin3 1Comprehensive Health Insights, Inc., Humana, Louisville, KY, USA; 2Health Economics and Outcomes Research, Forest Laboratories, LLC, an affiliate of Actavis, Inc., Jersey City, NJ, USA; 3Department of Medicine, University of...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-03-01
|
| Series: | International Journal of COPD |
| Online Access: | http://www.dovepress.com/impact-of-roflumilast-on-exacerbations-of-copd-health-care-utilization-peer-reviewed-article-COPD |